New research indicates that patients who stop using popular weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise programs.
Research printed in a prominent health publication demonstrates that while obese individuals frequently drop about a fifth of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Users buying these medications need to be cognizant of the danger of quick weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb.
Such speed of recovery implies a reversion to original weight in about a year and a half.
Analyzing Treatments
The study, which looked at 37 of studies involving over 9,000 of patients, contrasted the results of these new drugs with conventional dieting.
Scientists emphasize that individuals who shed pounds through diet and exercise generally see a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Experts propose the mechanism of the injections accounts for the amplified rebound.
These medications imitate a natural hormone called GLP-1, which controls appetite.
"Artificially providing the hormone concentrations far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication leads to hunger is no longer kept in check, making excessive eating a significant risk."
An Ongoing Condition?
Medical guidelines suggest the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Professionals argue that, given the high risk of weight regain, the treatment might need to be ongoing.
This opinion is supported by drug manufacturers, who state that the findings "underscore the persistent nature of obesity," comparing it to managing diseases like high blood pressure.
User Experiences
People who have stopped the jabs report a powerful return of cravings.
"It felt as if a trigger that goes on and you're instantly starving," recalled one woman.
This challenge is compounded if patients have not developed lasting lifestyle or habit changes during therapy.
Significant Use
Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Use is higher among women compared to men.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
Finally, researchers caution that while these medications are potent tools for weight loss, they are not a magic fix and maintained weight loss relies on combined lifestyle management.
